Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Yao xue xue bao = Acta pharmaceutica Sinica

• Publication date

  2006-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 16856472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• MicroRNA-135a participates in the development of astrocytes derived from bacterial meningitis by downregulating HIF-1α.

  2019cites this paper
• Targeting Malignant Brain Tumors with Antibodies

  2017cites this paper
• P50DEVELOPING A PHYSIOLOGICALLY RELEVANT BLOOD BRAIN BARRIER MODEL FOR THE STUDY OF DRUG DISPOSITION IN GLIOMA

  2014cites this paper
• Diagnostic and therapeutic uses of nanomaterials in the brain.

  2014cites this paper
• Methodologies to Assess Drug Permeation Through the Blood–Brain Barrier for Pharmaceutical Research

  2013cites this paper
• Prediction of passive blood-brain barrier permeability with PAMPA: from small molecules to complex formulations

  2013cites this paper
• A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein.

  2011cites this paper
• DBS-relevant electric fields increase hydraulic conductivity of in vitro endothelial monolayers

  2010cites this paper
• OPINION ON SAFETY OF NANOMATERIALS IN COSMETIC PRODUCTS

  2008cites this paper